Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Considerations for implementing a new combination vaccine into managed care.

Lawrence Mullany

    The American Journal of Managed Care
    |February 5, 2003
    PubMed
    Summary

    Managed care evaluates new vaccines based on medical need, patient acceptance, and cost-effectiveness. The DTaP-HepB-IPV combination vaccine simplifies schedules, potentially improving outcomes and reducing healthcare expenses for childhood immunizations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measured and estimated glomerular filtration rate.

    The New England journal of medicine·2006
    Same author

    Assessment of drug therapy management and the prevalence of heart failure in a managed care population with hypertension.

    Journal of managed care pharmacy : JMCP·2004
    Same author

    ISPOR Code of Ethics for Researchers background article--report of the ISPOR Task Force on Code of Ethics for Researchers.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2004
    See all related articles

    Area of Science:

    • Pediatric immunization strategies
    • Public health policy
    • Vaccine pharmacoeconomics

    Background:

    • Childhood disease control relies on vaccination efforts by healthcare providers.
    • Managed care organizations (MCOs) play a role in delivering affordable, quality healthcare.
    • Vaccination programs are crucial for public health and disease prevention.

    Purpose of the Study:

    • To outline the decision-making process for managed care when adopting new vaccines.
    • To assess the criteria MCOs use for vaccine implementation.

    Main Methods:

    • Review of managed care considerations for vaccine adoption.
    • Analysis of a new combination vaccine (DTaP-HepB-IPV) based on established criteria.

    Main Results:

    • Managed care assesses medical necessity, consumer acceptance, and pharmacoeconomic benefits.
    • DTaP-HepB-IPV shows comparable immunogenicity and safety to individual vaccines.
    • Combination vaccines simplify schedules, reduce infant injections, and may improve compliance.
    • Potential pharmacoeconomic benefits include reduced visits, administration costs, and needlestick injuries.

    Conclusions:

    • DTaP-HepB-IPV is positioned to meet managed care criteria for medical appropriateness, consumer acceptance, and pharmacoeconomic value.
    • Combination vaccines offer a favorable value proposition for managed healthcare plans.

    Related Experiment Videos